Over a 1 year period 3296 specimens submitted for fungal culture were plated onto routine mycological media (RM) and CHROMagar Candida (CaC) to evaluate the capability of CaC to improve on RM. With RM, cultures producing single yeast isolates were identified from 802 specimens. CaC produced similar results, with 76 % agreement. Of 761 specimens that yielded a single Candida species by RM, 615 (81 %) produced one or more yeast isolates using CaC. Of concern, 132 negative CaC cultures corresponded to specimens that yielded C. albicans alone on RM. When yeasts were recovered, CaC correctly identified 98 % of C. albicans, 93 % of Candida tropicalis, 96 % of Candida glabrata and 100 % of Candida krusei based on typical colours. CaC did potentially improve on RM by detecting yeasts in 91 specimens that yielded none by routine methods. CaC was noted to recover more yeast isolates than RM when mixed cultures were detected. Overall, the role of CaC in improving RM appears limited.
AinscoughS.,
KibblerC. C.1998; An evaluation of the cost-effectiveness of using CHROMagar for yeast identification in a routine microbiology laboratory. J Med Microbiol 47:623–628[CrossRef]
BaumgartnerC.,
FreydiereA. M.,
GilleY.1996; Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J Clin Microbiol 34:454–456
Beck-SagueC.,
JarvisW. R.1993; National Nosocomial Infections Surveillance System: secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. J Infect Dis 167:1247–1251[CrossRef]
BeightonD.,
LudfordR.,
ClarkD. T. & 9 other authors; 1995; Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol 33:3025–3027
BernalS.,
MazuelosE. M.,
GarciaM.,
AllerA. I.,
MartinezM. A.,
GutierrezM. J.1996; Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis 24:201–204[CrossRef]
BoucharaJ. P.,
DeclerckP.,
CimonB.,
PlanchenaultC.,
de GentileL.,
ChabasseD.1996; Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations. Clin Microbiol Infect 2:202–208[CrossRef]
CookeV. M.,
MilesR. J.,
PriceR. G.,
MidgleyG.,
KhamriW.,
RichardsonA. C.2002; New chromogenic agar medium for the identification of Candida spp. Appl Environ Microbiol 68:3622–3627[CrossRef]
EdmondM. B.,
WallaceS. E.,
McClishD. K.,
PfallerM. A.,
JonesR. N.,
WenzelR. P.1999; Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29:239–244[CrossRef]
FreydiereA. M.,
BuchailleL.,
GilleY.1997; Comparison of three commercial media for direct identification and discrimination of Candida species in clinical specimens. Eur J Clin Microbiol Infect Dis 16:464–467[CrossRef]
HospenthalD. R.,
MurrayC. K.,
BeckiusM. L.,
GreenJ. A.,
DooleyD. P.2002; Persistence of pigment production by yeast isolates grown on CHROMagar Candida media. J Clin Microbiol 40:4768–4770[CrossRef]
HospenthalD. R.,
MurrayC. K.,
RinaldiM. G.2004; The role of antifungal susceptibility testing in the therapy of candidiasis. Diagn Microbiol Infect Dis 48:153–160[CrossRef]
HouangE. T.,
ChuK. C.,
KoehlerA. P.,
ChengA. F.1997; Use of CHROMagar Candida for genital specimens in the diagnostic laboratory. J Clin Pathol 50:563–565[CrossRef]
KirkpatrickW. R.,
RevankarS. G.,
McAteeR. K. & 7 other authors; 1998; Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar Candida screening and susceptibility testing of isolates. J Clin Microbiol 36:3007–3012
Lopez-RibotJ. L.,
McAteeR. K.,
PereaS.,
KirkpatrickW. R.,
RinaldiM. G.,
PattersonT. F.1999; Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 43:1621–1630
OddsF. C.,
BernaertsR.1994; CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 32:1923–1929
Rangel-FraustoM. S.,
WiblinT.,
BlumbergH. M. & 8 other authors; 1999; National Epidemiology of Mycoses Survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 29:253–258[CrossRef]
ReddingS. W.,
ZellarsR. C.,
KirkpatrickW. R. & 7 other authors; 1999; Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer. J Clin Microbiol 37:3896–3900
WillingerB.,
HillowothC.,
SelitschB.,
ManafiM.2001; Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol 39:3793–3795[CrossRef]